These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1485 related articles for article (PubMed ID: 32702310)

  • 1. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
    Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.
    Gheorghe A; Maringe C; Spice J; Purushotham A; Chalkidou K; Rachet B; Sullivan R; Aggarwal A
    Eur J Cancer; 2021 Jul; 152():233-242. PubMed ID: 34049776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
    Mafham MM; Spata E; Goldacre R; Gair D; Curnow P; Bray M; Hollings S; Roebuck C; Gale CP; Mamas MA; Deanfield JE; de Belder MA; Luescher TF; Denwood T; Landray MJ; Emberson JR; Collins R; Morris EJA; Casadei B; Baigent C
    Lancet; 2020 Aug; 396(10248):381-389. PubMed ID: 32679111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing patterns of mortality during the COVID-19 pandemic: Population-based modelling to understand palliative care implications.
    Bone AE; Finucane AM; Leniz J; Higginson IJ; Sleeman KE
    Palliat Med; 2020 Oct; 34(9):1193-1201. PubMed ID: 32706299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
    Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
    Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales.
    Verhagen MD; Brazel DM; Dowd JB; Kashnitsky I; Mills MC
    BMC Med; 2020 Jun; 18(1):203. PubMed ID: 32594909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study.
    Panovska-Griffiths J; Kerr CC; Stuart RM; Mistry D; Klein DJ; Viner RM; Bonell C
    Lancet Child Adolesc Health; 2020 Nov; 4(11):817-827. PubMed ID: 32758453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.
    Davies NG; Barnard RC; Jarvis CI; Russell TW; Semple MG; Jit M; Edmunds WJ; ;
    Lancet Infect Dis; 2021 Apr; 21(4):482-492. PubMed ID: 33357518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
    Jewell BL; Mudimu E; Stover J; Ten Brink D; Phillips AN; Smith JA; Martin-Hughes R; Teng Y; Glaubius R; Mahiane SG; Bansi-Matharu L; Taramusi I; Chagoma N; Morrison M; Doherty M; Marsh K; Bershteyn A; Hallett TB; Kelly SL;
    Lancet HIV; 2020 Sep; 7(9):e629-e640. PubMed ID: 32771089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
    Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
    Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.
    Davies NG; Kucharski AJ; Eggo RM; Gimma A; Edmunds WJ;
    Lancet Public Health; 2020 Jul; 5(7):e375-e385. PubMed ID: 32502389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation.
    Duffy SW; Seedat F; Kearins O; Press M; Walton J; Myles J; Vulkan D; Sharma N; Mackie A
    Br J Cancer; 2022 May; 126(9):1355-1361. PubMed ID: 35110696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
    Degeling K; Baxter NN; Emery J; Jenkins MA; Franchini F; Gibbs P; Mann GB; McArthur G; Solomon BJ; IJzerman MJ
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):359-367. PubMed ID: 33567163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.
    Sud A; Jones ME; Broggio J; Loveday C; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Gronthoud F; Ward P; Handy JM; Yousaf N; Larkin J; Suh YE; Scott S; Pharoah PDP; Swanton C; Abbosh C; Williams M; Lyratzopoulos G; Houlston R; Turnbull C
    Ann Oncol; 2020 Aug; 31(8):1065-1074. PubMed ID: 32442581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
    Morris EJA; Goldacre R; Spata E; Mafham M; Finan PJ; Shelton J; Richards M; Spencer K; Emberson J; Hollings S; Curnow P; Gair D; Sebag-Montefiore D; Cunningham C; Rutter MD; Nicholson BD; Rashbass J; Landray M; Collins R; Casadei B; Baigent C
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):199-208. PubMed ID: 33453763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Zhang J; Litvinova M; Wang W; Wang Y; Deng X; Chen X; Li M; Zheng W; Yi L; Chen X; Wu Q; Liang Y; Wang X; Yang J; Sun K; Longini IM; Halloran ME; Wu P; Cowling BJ; Merler S; Viboud C; Vespignani A; Ajelli M; Yu H
    Lancet Infect Dis; 2020 Jul; 20(7):793-802. PubMed ID: 32247326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.